Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can removing drains sooner after pancreatic surgery cut infections?

NCT ID NCT01368094

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether removing surgical drains early (4 days after surgery) instead of the usual 10-15 days reduces infections after pancreaticoduodenectomy, a major operation for pancreatic tumors. 141 patients were included, and those without a pancreatic leak were randomly assigned to early or standard drain removal. The goal was to see if early removal lowers the rate of surgical site infections within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If early drain removal reduces infections, it could become the new standard practice for pancreatic surgery recovery.
What could go wrong
This is a completed study with 141 participants, so results are final. However, the approach may not work for all patients, especially those with complications like pancreatic fistula.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

141 people

The number who actually took part.

Start date

Jun 2011

Finished

Jan 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pancreatic tumor regardless of its nature: All patients requiring PD (following thesaurus or multidisciplinary team council recommendation) for this indication will be included. * Ability to participate in a clinical research protocol. * Given informed consent. Exclusion Criteria: * History of pancreatic surgery or biliary diversion and / or digestive * Patient taken in charge for chronic pancreatitis without tumor * History of supramesocolic radiotherapy * Sick supported emergency * Physical or mental condition does not allow participation in the study * Contra-indication to surgery * ASA classification (American Society of Anesthesiologists) IV-V or life expectancy \<48 * Pregnancy or breastfeeding * Patient under guardianship or private patient of liberty by a judicial or administrative decision * Age under 18yo

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pancreatic disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens

    Amiens, Picardie, 80000, France

  • Centre Hospitalier Charles Nicolle

    Rouen, 76 031, France

  • Centre Hospitalier Régional Universitaire Claude Huriez

    Lille, 59037, France

  • Centre Hospitalier Saint-Martin

    Caen, 14050, France

  • Centre Hospitalier de Beauvais

    Beauvais, 60000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.